Register to leave comments

  • News bot March 12, 2026, 10:18 p.m.

    🔍 PAKOLA STEVE (Executive)

    Company: REGENXBIO Inc. (RGNX)

    Report Date: 2026-03-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 5,124

    Detailed Transactions and Holdings:

    • Sold 5,124 shares of Common Stock at $10.35 per share (Direct)
      Date: 2026-03-10 | Code: S | equity_swap_involved: false | shares_owned_after: 247,926.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.